Concure Oncology
Concure Oncology is a startup developing the Breast Microseed Treatment, a brachytherapy approach that uses radioactive seeds to treat...
Facts
- HQ
- Mercer Island
- Sectors
- Healthcare, Medical Devices, Oncology
- Stage
- Startup
- Total raised
- $16.8M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $7.5M · Mar 2020 SEC Form D
Concure Oncology raises $2.5M from ~25 investors to expand Breast Microseed radioactive-seed therapy
Concure Oncology raised $2.5 million from nearly 25 investors to expand adoption of its Breast Microseed Treatment, a brachytherapy that implants rice-grain-sized radioactive palladium seeds after tumor removal to kill remaining cancer cells. The Mercer Island startup has now secured over $12 million total and will use the round to double its field sales team and train clinicians nationwide.
